Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEO 90100 in adolescent plaque psoriasis
NCT02387853Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- Mar 2016
- Primary completion
- Mar 2018
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
Phase 2, open-label, single-arm trial of calcipotriol in plaque psoriasis, sponsored by LEO Pharma. Primary endpoints: Number of Subjects With Adverse Events, Number of Subjects With Serum Cortisol Concentration of ≤18 mcg/dl at 30 Minutes After ACTH-challenge and 3 more. Started Mar 2016; status: completed.
02
Drugs
calcipotriol
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02387853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02387853.